Date Time
University of Helsinki and University of Eastern Finland shareholders in a Finnish COVID vaccine company
Rokote Laboratories Finland Ltd., is a newly-founded, Finnish academic spin-out working to develop and introduce to the markets a nasal spray vaccine against COVID. The vaccine is based on research carried out at the University of Helsinki and the University of Eastern Finland.
The founders and board members of the company are the vaccine developers Academy Professor Seppo Ylä-Herttuala from the University of Eastern Finland, Professor Kalle Saksela and Professor Kari Alitalo from the University of Helsinki, and Mr Pasi Kemppainen, MSc (Techn.). The University of Helsinki and the University of Eastern Finland are also co-founders of, and shareholders in, the company.
These updates are republished press releases and communications from members of the Science|Business Network
University of Eastern Finland to coordinate a €15M Horizon 2020 research project for sleep apnoea
Sleep Revolution is a multidisciplinary and international research and development project aimed at reforming the diagnostics and treatment of sleep apnoea. The European Commission recently granted the project almost 15 million euros of funding from the Horizon 2020 Framework Programme for Health, Demographic Change and Wellbeing.
The objective of the project is to revolutionise research, diagnosis, and treatment practices of sleep apnoea. To achieve this goal, the project will develop methods based on machine learning and artificial intelligence to assess the severity of, and the need for treatment in, sleep apnoea. A total of 37 research institutes, hospitals, and companies will participate in the project. The ultimate objective of the project is to draw up new internationa